Funds holding Kailera Therapeutics Inc
ISIN US4829311020 · United States
- Fund holders
- 11
- Of which ETFs
- 0 11 other funds
- Value held
- 95.1M $
- Share of capital
- 2.9 % of 129.6M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2,127,264 | 53.2M $ | 0.14 % | 1.64 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 587,097 | 14.7M $ | 0.02 % | 0.45 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 500,000 | 12.5M $ | 0.43 % | 0.39 % | as of Apr 30, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 188,198 | 4.7M $ | 0.65 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 146,385 | 3.7M $ | 0.35 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 121,300 | 3M $ | 0.02 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 109,300 | 2.7M $ | 0.02 % | 0.08 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 10,837 | 270.9K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| The Hartford Small Cap Growth Fund HARTFORD MUTUAL FUNDS II, INC | 8,000 | 200K $ | 0.07 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 3,360 | 84K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 2,000 | 50K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 0.65 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.43 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.35 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 0.14 % | as of Apr 30, 2026 ↗ |
| The Hartford Small Cap Growth Fund HARTFORD MUTUAL FUNDS II, INC | 0.07 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 0.02 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 0.01 % | as of Apr 30, 2026 ↗ |
Declared shareholders of Kailera Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BCPE Perseus Investor, LP | 20.27 % | 26,255,581 | as of Apr 16, 2026 · SCHEDULE 13D |
| BCLS Fund IV Investments, L.P. | 17.43 % | 22,583,268 | as of Apr 16, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding Kailera Therapeutics Inc". https://titelia.com/en/stocks/kailera-therapeutics-inc-US4829311020